E-LIB Suche - Ergebnisse für: Mei, Matthew

1

P1200: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED OR REFRAC..:

Spurgeon, Stephen ; Mei, Matthew ; Barr, Paul M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430916/. , 2023

2

Editorial: Advances in the treatment of Hodgkin lymphoma:

Mei, Matthew ; Perini, Guilherme ; Ramchandren, Radhakrishnan
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013146/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Ce..:

Ladbury, Colton ; Dandapani, Savita ; Hao, Claire...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046245/. , 2023

Link: http://www.ncbi.nlm.nih...

4

Bendamustine vs. fludarabine/cyclophosphamide lymphodepleti..:

Sidana, Surbhi ; Hosoya, Hitomi ; Jensen, Alexandria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576036/. , 2023

Link: http://www.ncbi.nlm.nih...

5

The Mutational Landscape in Chronic Myelomonocytic Leukemia..:

Mei, Matthew ; Pillai, Raju ; Kim, Soyoung...
https://jdc.jefferson.edu/medoncfp/220. , 2023

Link: https://jdc.jefferson.ed..

6

Autologous Stem Cell Transplantation in Hodgkin Lymphoma—La..:

Samara, Yazeed ; Mei, Matthew
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996995/. , 2022

Link: http://www.ncbi.nlm.nih...

7

P112: Phase II Trial of Brentuximab Vedotin plus ibrutinib ..:

Mei, Matthew ; Palmer, Joycelynne ; Maddocks, Kami...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642064/. , 2022

Link: http://www.ncbi.nlm.nih...

8

P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporin..:

Kambhampati, Swetha ; Mei, Matthew ; Chen, Lu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642054/. , 2022

Link: http://www.ncbi.nlm.nih...

9

Peritransplantation ruxolitinib administration is safe and ..:

Ali, Haris ; Tsai, Ni-Chun ; Synold, Timothy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905711/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoi..:

Herrera, Alex F ; Palmer, Joycelynne ; Adhikarla, Vikram...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153018/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Late and very late relapsed acute lymphoblastic leukemia: c..:

Aldoss, Ibrahim ; Pillai, Raju ; Yang, Dongyun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253853/. , 2021

Link: http://www.ncbi.nlm.nih...

12

The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI)..:

Gordon, Max ; Kaempf, Andy ; Sitlinger, Andrea...
qt5b27p9dx. , 2021

Link: https://escholarship.org..

13

The chronic lymphocytic leukemia comorbidity index (CLL-CI)..:

Gordon, Max J ; Kaempf, Andy ; Sitlinger, Andrea...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416936/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Impact of type of reduced-intensity conditioning regimen on..:

Ahmed, Sairah ; Ghosh, Nilanjan ; Ahn, Kwang Woo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575614/. , 2020

Link: http://www.ncbi.nlm.nih...

15

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transpl..:

Mei, Matthew ; Tsai, Ni-Chun ; Mokhtari, Sally...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822504/. , 2020

Link: http://www.ncbi.nlm.nih...